Insulin aspart, recombinant Subcutaneous and Valproate sodium Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Valproate sodium Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproate sodium (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Valproic acid
- Insulin aspart, recombinant Subcutaneous-Valproic Acid and Derivatives
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Capsules
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Liquid
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Oral Solution
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Syrup
- Valproate sodium Intravenous-Insulin degludec
- Valproate sodium Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Valproate sodium Intravenous-Insulin Degludec (U-100) Vials
- Valproate sodium Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Valproate sodium Intravenous-Insulin degludec and liraglutide
- Valproate sodium Intravenous-Insulin degludec and liraglutide Subcutaneous